2021
DOI: 10.1002/ccr3.3783
|View full text |Cite
|
Sign up to set email alerts
|

Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report

Abstract: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…This results in the phagocytosis of these platelets hence leading to a drop in circulating platelet count and, ultimately, thrombocytopenia [ 50 ]. Thrombopoietin receptor agonists and corticosteroids are most commonly used in the treatment of ITP [ 53 ].…”
Section: Resultsmentioning
confidence: 99%
“…This results in the phagocytosis of these platelets hence leading to a drop in circulating platelet count and, ultimately, thrombocytopenia [ 50 ]. Thrombopoietin receptor agonists and corticosteroids are most commonly used in the treatment of ITP [ 53 ].…”
Section: Resultsmentioning
confidence: 99%